Brawn Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve inter alia the unaudited financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brawn Biotech Ltd has informed the BSE that its Board of Directors will meet on 13 August 2025 to consider and approve the unaudited financial results for the quarter ended 30 June 2025. This is a routine regulatory disclosure under SEBI Listing Regulations. The trading window for insiders has been closed from the date of intimation and will reopen on 16 August 2025, in line with insider trading rules. No financial figures or business decisions have been disclosed in this filing.
This is a standard pre-results announcement and by itself has no direct impact on the stock price. Investors should watch for the actual Q1 FY26 results when published, as those numbers will be the real driver of any price movement.